Fuertes, Thelma C.
HRN: 22-58-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/28/2025
05/04/2025
IVTT
300mg
Every 6hrs
Non Healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes